I nearly shut down my longevity company last year. I was asking myself what one should build on the eve of superintelligence. The answer is obvious now: cure all diseases. But this wasn’t an obvious path for an individual like myself 12 months ago. Sid Sijbrandij hadn’t yet put his cancer into remission by going founder mode. The Australian engineer hadn’t shrunk his dog’s tumor by building a custom mRNA vaccine. And Kate and I hadn’t yet been diagnosed with disease. Curing disease was something that big, billion dollar companies did over ten years. Not individuals. That’s now changed. Two weeks ago, I started focusing my company, Immortals, on building the infrastructure to allow individuals to discover and resolve their own health issues. Kate and I are the first customers as we both try to address our recent disease diagnoses. If you’re a cracked engineer looking for a hard challenge, come build this with me. Immortals will continue to be best-in-class with nutrition, GLP-1s, longevity medicines, hormones, peptides, biomarkers and concierge medicine. We’re now adding induced pluripotent stem cells, organoids, deep cellular characterization, and personalized therapy development among other things. I hope what we build in the coming year makes current health care look like it’s medicine from the 1500s. Hit me up if you’re building biotech that matches in goal. When our basic needs are met, solving all diseases is the only rational next thing to do. And to not wait around for someone else to do it on your behalf.